Revista Newslab Edição 182

Autora: Thais Aguilhera Miranda.
ARTIGO CIENTÍFICO I
MARONE, G. et al. The Wiskott-Aldrich syndrome: studies
of platelets, basophils and polymorphonuclear
leucocytes. Br J Haematol, v. 62, n. 4, p. 737-45, 1986
VANHOORELBEKE, K. et al. Occurrence of the Asn-
45Ser mutation in the GPIX gene in a Belgian patient
with Bernard Soulier syndrome. Platelets, v.
12, n. 2, p. 114-20, 2001.
TORTI, M. et al. Rap1B and Rap2B translocation to
the cytoskeleton by von Willebrand factor involves
Fc gamma II receptor-mediated protein tyrosine
phosphorylation. J Biol Chem, v. 274, n. 19, p.
13690-97, 1999
WHITE, B. N.; COX, A. C.; TAYLOR, F. B. J. The procoagulant
effect of platelets on conversion of prothrombin
to thrombin in nonanticoagulated plasma.
J Lab Clin Med, v. 95, n. 6, p. 827-41, 1980.
MINISTÉRIO DA SAÚDE; Secretaria de Atenção à
Saúde Coordenação‐Geral de Sangue e Hemoderivados;
Manual de diagnóstico laboratorial das coagulopatias
hereditárias e plaquetopatias; Brasília
DF 2012.
BATES, E. R.; LAU, W. C. Controversies in antiplatelet
therapy for patients with cardiovascular disease.
Circulation, v. 111, n. 7, p. 267-71, 2005.
ERHARDTSEN, E. To general haemostasis: the
evidence-based route. Pathophysiol Haemost
Thromb, v. 32, n. 1, p. 47-52, 2002.
STASSEN, J. M.; ARNOUT, J.; DECKMYN, H. The hemostatic
system. Curr Med Chem, v. 11, n. 17, p.
2245-60, 2004.
ANDREWS, R. K.; BERNDT, M. C. Platelet physiology
and thrombosis. Thromb Res, v. 114, n. 5, p.
447-53, 2004.
ALEVRIADOU, B. R. et al. Real-time analysis of shear-
-dependent thrombus formation and its blockade
by inhibitors of von Willebrand-factor binding to
platelets. Blood, v. 81, n.5, p. 1263-66, 1993
CANOBBIO, I.; BALDUINI, C.; TORTI, M. Signalling
through the platelet glycoprotein Ib-V-IX complex.
Cell Signal, v. 16, n. 12, p. 1329-34, 2004
CICMIL, M. et al. Collagen, convulxin and thrombin
stimulate aggregation-independent tyrosine phosphorylation
of CD31 in platelets. Evidence for the
involvement of Src family kinases. J Biol Chem, v.
275, p. 27339-47, 2000.
FARNDALE, R. W. et al. The role of collagen in thrombosis
and haemostasis. J Thromb Haemost, v. 2, n.
1, p. 561-73, 2004.
GAWAZ, M.; NEUMAN, F. J.; SCHÖMIG, A. Evaluation
of platelet membrane glycoproteins in coronary
artery disease. Consequences for diagnosis and
therapy. Circulation, v. 99,n. 1, p. 1-11, 1999.
FLAUMENHAFT, R. Molecular basis of platelet granule
secretion. Arterioscler Thromb Vasc Biol, v. 23,
n.7, p. 1152-60, 2003.
GIBBINS, J. M. Platelet adhesion signaling and the
regulation of thrombus formation. J Cells Sci, v. 117,
p. 3415-25, 2004.
ISRAELS, S. J. Platelet function in newborn. In:
MICHELSON, A. D. Platelets. California: Academic
Press, 2002.
KASIRER-FRIEDE, A. et al. Signaling through GP Ib-
-IX-V activates alpha IIb beta 3 independently of
other receptors. Blood, v. 103, n. 9, p. 3403-11, 2004.
MOSESSON, M. W. Fibrinogen and fibrin structure
and functions. J Thromb Haemost, v. 3, n. 8, p. 1894-
04, 2005.
MURUGAPPAN, S.; SHANKAR, H.; KUNAPULI, S. P.
Platelet
receptors for adenine nucleotides and thromboxane
A2. Sem Thromb Hemost, p. 30, n. 4, p. 411-18, 2004
NESBIT, W. S. et al. Distinct glycoprotein Ib/V/IX and
integrin alpha (Iib) beta (3)-dependent calcium signals
cooperatively regulate platelet adhesion under
flow. J Biol Chem, v. 277, n. 4, p. 2965-72, 2002.
PLOW, E. F.; D’SOUZA, S. E.; GINSBERG, M. H. Ligand
binding to GP IIb/IIIa: a status report. Sem Thromb
Hemost, v. 18, p. 324-32, 1992.
SAVAGE, B.; SALDIVAR, E.; RUGGERI, Z. M. Initiation
of platelet adhesion by arrest onto fibrinogen or
translocation on von Willebrand factor. Cell, v. 84,
n. 2, p. 289-97, 1996.
SIXMA, J. J. et al. Platelet adhesion to collagen: an
update. Thromb Haemost, v. 78, n. 1, p. 434-38,
1997.
FERREIRA, C.N; SOUSA, M.O; DUSSE, L.M.S; CAR-
VALHO, M.G.; O novo modelo da cascata de coagulação
baseado nas superfícies celulares e suas
implicações; Revista Brasileira de Hematologia e
Hemoterapia, 2010;32(5):416-421.
BHATT DL, TOPOL EJ. Scientific and therapeutic advances
inantiplatelet therapy. Nat Rev Drug Discov.
2003;2:15---28,http://dx.doi.org/10.1038/nrd985.
GARG VP, HALPERIN JL. Novel antiplatelet and anticoagulantagents
in the cardiac care unit. Cardiol
Clin. 2013;31:533---44
GALE AJ. Continuing education course #2: Current
understandingof hemostasis. Toxicol Pathol.
2011;39:273---80.6
BAGLIN TP, KEELING DM, WATSON HG; British Committee
for Standards in Haematology. Guidelines
on oral anticoagulation (warfarin): third edition
– 2005 update. Br J Haematol 2006 Feb; 132 (3):
277-85.
ROBERT-EBADI H, LE GAL G, RIGHINI M. Use of anticoagulants
in elderly patients: practical recommendations.
Clin Interv Aging 2009; 4: 165-77. Terapêutica
antitrombótica para prevenção primária
e secundária do Acidente Vascular
CAVACO R., FONSECA T., GORJÃO CLARA J. Cerebral
Isquémico Cardioembólico – pontos de interesse
na orientação terapêutica. Serviço de Medicina Interna
3 do Centro Hospitalar Lisboa Norte Grupo de
Investigação e Tratamento do Doente Idoso (GITDI)
Vol 2, n° 2, abr/jun 2010.
FERREIRA, A C.P., MONTES, M B.A., FRANCESCHINI S
A. TOLOI, M R.T. Efeitos do contraceptivo oral contendo
20 μg de etinilestradiol e 150 μg de desogestrel
sobre os sistemas de coagulação e fibrinólise.
Rev.bras.hematol.hemoter., 2000, 22(2): 77-87
ROBERT GH et al. Lessons from Stroke Prevention in
Atrial Fibrillation Trials. Ann Intern Med 2003: 138:
831-838.
EUROPEAN ATRIAL FIBRILLATION TRIAL (EAFT) Study
Group. Lancet 1993: 342 (8882): 1255-1262.
ACC/AHA/ESC 2006 Guidelines for the Management
of Patients with Atrial Fibrillation. Circulation;
2006 114: e257-e354.
GRANT JD, STEVENS SM, WOLLER SC, LEE EW, KEE
ST, LIU DM, et al. Diagnosis and management of
upper extremity deep-vein thrombosis in adults.
Thromb Haemost. 2012;108(6):1097-108.
ENGELBERGER RP, KUCHER N. Management of
deep vein thrombosis of the upper extremity. Circulation.
2012;126(6):768-73.
MAIA, H OM. Trombose venosa profunda num
membro superior em mulher a fazer anticoncepcional
oral e com trombofilia hereditária – Factor V
Leiden. Rev Port Med Geral Fam 2015;31:121-4
WORLD HEALTH ORGANIZATION. Medical eligibility
criteria for contraceptive use. 4th ed. Geneva:
WHO; 2010. ISBN 9789241563888
TZANKOVA V, PETROV V, DANCHEV N. Impact of
oralcontraceptives and smoking on arterial and
deep venousthrombosis: a retrospective case-control
study. Biotechnologye Biotechnological Equipment.
2010;24:2026–30.
UM A, ANTTILA M, MÄENPÄÄ-LIUKKO K, RANTALA
ML, RAUTIAINENH, SOMMER WF, et al. Effects of
a monophasic combined oralcontraceptive containing
nomegestrol acetate and17boestradiol
compared with one containing levonorgestreland
ethinylestradiol on haemostasis, lipids and carbohydratemetabolism.
Eur J Contracept Reprod
Health Care.2011;16:444–57.
BONNEMA RA, MCNAMARA MC, SPENCER AL. Contraceptionchoices
in women with underlying medical
conditions. AmFam Physician. 2010;82:621–8.
COSTA, P A.; SANTOS, P. Plasma rico em plaquetas:
uma revisão sobre seu uso terapêutico. Universidade
alto vale do rio do peixe (uniarp) curso de farmácia
caçador, sc, 2014.
ISAAC: Li J, CHEN J, Kirsner R. Pathophysiology of
acute wound healing. Clin Dermatol. 2007;25(1):9-18
BROUGHTON G 2nd, JANIS JE, Attinger CE. The basic
science of wound healing. Plast Reconstr Surg.
2006;117(7 Suppl):12S-34S.
TOWNSEND CM, BEAUCHAMP D, Evers M, Mattox
KL. Sabiston textbook of surgery. St Louis, MO: Elsevier;
2011. p.192-207.
GURTNER GC, WERNER S, BARRANDON Y, LON-
GAKER MT. Wound repair and regeneration. Nature.
2008;453:314-21.
KIERSZENBAUM AL. Histologia e biologia celular:
uma introdução à patologia. Rio de Janeiro: Elsevier;
2004. p.19-22.
SINGER AD, CLARK RAF. Cutaneous wound healing.
New Engl J Med. 1999;341:738-46.
GRAY H, et al. Gray’s anatomy: the anatomical basis
of medicine and surgery. Nova Iorque: Churchill Livingstone;
1995. p.395-416.
KUHN K. Structure and biochemistry of collagen.
Aesthetic Plast Surg. 1988;9(2):141-4.
KIERSZENBAUM AL. Histologia e biologia celular:
uma introdução à patologia. Rio de Janeiro: Elsevier;
2004. p.319-39.
RYAN DH. Automated analysis of blood cells. In:
Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ &
Silberstein LE eds. Hematology – Basic Principles
and Practice 2nd. Ed. 1995. New York, Churchill Livingstone,
2223-35.
CHAPMAN M. Hematology review criteria and its
impact on workflow and productivity. Lab hematol
1997;1:48-52.
SCHILLING, V. Técnica. El cuadro hemático y su valor
en la clínica. 2° ed. Editorial Labor, S.A. 1934. Barcelona,
Madrid, Buenos Aires, p. 10.
LASMAR M.C; SOUTO J.B.G; ET AL. Contagem de
plaquetas: método manual versus método automatizado.
RBAC, v. 35, p 113-116, 2003
DANTAS T.A.C, BARBOSA I.R, ET AL. Estudo Comparativo
entre Métodos de Contagem de Plaquetas.
Newslab ed. 98 2010
SILVA, M.D.L; NARDIN, J.M. Avaliação manual do número
de plaquetas em pacientes oncológicos que
apresentem trombocitopenia. Cadernos da Escola
de Saúde, v.8, p. 60-73, 2012
MATSUNO K, ISHIZUKA S. NEW TECHNOLOGY OF
AUTOMATED BLOOD
CELL DIFFERENTIAL COUNTING. RINSHO BYORI
1998;46:361-6.
DUSSE, L M; RIBEIRO A P R; ET AL. INFLUÊNCIA DA
MENSTRUAÇÃO NO NÚMERO DE PLAQUETAS CIR-
CULANTES. JORNAL BRASILEIRO DE PATOLOGIA E
MEDICINA LABORATORIAL; RIO DE JANEIRO, V. 38,
N. 4, P. 297-299, 2002.
40 Revista NewsLab Edição 182 | Março 2024